Single-Gene Testing For Driving Mutations Does Not Provide As Much Clinically Relevant Information As Targeted NGS For Patients With NSCLC, Research Indicates.

Cancer Therapy Advisor (8/1, Hernandez) reports that research indicates “single-gene testing for driving mutations does not provide as much clinically relevant information as targeted next-generation sequencing (NGS) for patients with non-small cell lung...